SNY logo

Sanofi Aventis (SNY)$44.29

Market Cap: 133.33 BCurrency: USD

Research Snapshot

Static fundamentals, valuation context, and investor signals for Sanofi Aventis (SNY).

HEALTHCARE
DRUG MANUFACTURERS - GENERAL

Valuation

N/A

EV/FCF, N/A FCF yield

Quality

N/A

ROIC, N/A FCF margin

Growth

N/A

5Y sales (revenue) CAGR

Balance sheet

N/A

Debt/equity, N/A current ratio

Superinvestors

3

Top: Dodge & Cox (0.8%)

Strengths to research

No strong positive screening signals were detected from the checked-in dataset.

Watchouts

  • Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 5 periods
Stock snapshot: May 24, 2026
Static dataset: May 25, 2026

Quality Scorecard

Build-time composite score for SNY.

Grade F
0
/ 100
Compare to:
LLYJNJUNHABBVNVO

Peer Comparison

Target stock against 8 market-cap comparable peers.

Heat map: red worst to green best
SNY
Target
Sanofi Aventis$133.3BN/AN/AN/AN/AN/AN/AN/AN/A
PFEPfizer Inc.$135.4B19.0x14.8x9.0%8.5%14.5%N/AN/AN/A
GILDGilead Sciences$128.0B19.8x15.4x17.9%3.6%32.1%N/A1.7xN/A
AMGNAmgen$150.6B23.8x24.2x12.2%7.6%22.0%N/A3.2xN/A
BMYBristol-Myers Squibb$101.9B17.2x10.6x11.1%2.5%26.7%N/AN/AN/A
MRKMerck & Co.$208.5B16.8x15.7x34.7%9.4%19.0%N/AN/AN/A
NVSNovartis AG$223.3BN/AN/AN/AN/AN/AN/AN/AN/A
GSKGSK plc$79.0BN/AN/AN/AN/AN/AN/AN/AN/A
RHHVFRoche Holdings AG DIV RT$263.8BN/AN/AN/AN/AN/AN/AN/AN/A

Financial Charts

No financial data available for SNY (annual).

3 superinvestors own SNY

Current quarter ownership and quarter-over-quarter share changes.

Superinvestor ownership
FundSharesValue% PortfolioQoQ Change
Dodge & Cox

Dodge & Cox

29,504,632$1.4B0.78%0.0%
Lee Ainslie

Maverick Capital

24,581$1M0.01%0.0%
Richard Pzena

Hancock Classic Value

19,088$920,0000.00%0.0%